Gougis, Paul

Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: Single-arm, open-label, multicentre, phase 3 trials

Clément, K., van den Akker, E., Argente, J., Bahm, A., Chung, W. K., Connors, H., De Waele, K., Farooqi, I. S., Gonneau-Lejeune, J., Gordon, G., et al. (2020) · The Lancet Diabetes & Endocrinology

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 492

Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

Salem, J.-E., Bretagne, M., Abbar, B., Leonard-Louis, S., Ederhy, S., Redheuil, A., Boussouar, S., Nguyen, L. S., Procureur, A., Stein, F., et al. (2023) · Cancer Discovery

Cancer Immunotherapy and BiomarkersInflammatory Myopathies and Dermatomyositis

Cited by 243

Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective

Gougis, P., Jochum, F., Abbar, B., Dumas, E., Bihan, K., Lebrun-Vignes, B., Moslehi, J., Spano, J.-P., Laas, E., Hotton, J., et al. (2024) · eClinicalMedicine

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 161

Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

Fenioux, C., Abbar, B., Boussouar, S., Bretagne, M., Power, J. R., Moslehi, J. J., Gougis, P., Amelin, D., Dechartres, A., Lehmann, L. H., et al. (2023) · Nature Medicine

Cancer Immunotherapy and BiomarkersMyasthenia Gravis and Thymoma

Cited by 83

Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward

Le Joncour, A., Frere, C., Martin-Toutain, I., Gougis, P., Ghillani-Dalbin, P., Maalouf, G., Vieira, M., Marcelin, A.-G., Salem, J.-E., Allenbach, Y., et al. (2021) · Autoimmunity Reviews

Systemic Lupus Erythematosus ResearchCOVID-19 Clinical Research Studies

Cited by 37